China, the Life Sciences Leader of 2020
10/11/10 Filed in: The Next Thing | Strategy
In Monitor’s recent report, “China, the Life Sciences Leader of 2020,” George Baeder and Michael Zielenziger find that China is poised to become the global leader in life science discovery and innovation within the next decade.
At a time when the global life sciences and pharmaceutical industries are beset by major challenges, including patent cliffs, skyrocketing costs of drug approvals and failures in key trials for potentially landmark new drugs, China has developed a strategy of targeted government investments. Through a variety of national and regional programs, China is spending billions on a new health care “safety net,” encouraging the growth of life science parks and startups, financing the development of a high-quality research infrastructure and luring back tens of thousands of Western-educated Chinese researchers. Read more... (PDF 7MB)
At a time when the global life sciences and pharmaceutical industries are beset by major challenges, including patent cliffs, skyrocketing costs of drug approvals and failures in key trials for potentially landmark new drugs, China has developed a strategy of targeted government investments. Through a variety of national and regional programs, China is spending billions on a new health care “safety net,” encouraging the growth of life science parks and startups, financing the development of a high-quality research infrastructure and luring back tens of thousands of Western-educated Chinese researchers. Read more... (PDF 7MB)